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Abstract 
The pathogenesis of hepatic encephalopathy (HE) in cirrhosis is multifactorial and 
ammonia is thought to play a key role. Astroglial dysfunction is known to be present 
in HE. Astrocytes are extensively connected by gap junctions formed of connexins, 
which also exist as functional hemichannels allowing exchange of molecules 
between the cytoplasm and the extracellular milieu. The astrocyte-neuron lactate 
shuttle hypothesis suggests that neuronal activity is fuelled (at least in part) by 
lactate provided by neighbouring astrocytes. We hypothesised that in HE, astroglial 
dysfunction could impair metabolic communication between astrocytes and neurons. 
In this study we determined whether hyperammonemia leads to hemichannel 
dysfunction and impairs lactate transport in the cerebral cortex using rat models of 
HE (bile duct ligation [BDL] and induced-hyperammonemia [HA]) and also evaluated 
the effect of ammonia-lowering treatment (ornithine phenylacetate, OP). Plasma 
ammonia concentration in BDL rats was indeed significantly reduced by OP 
treatment. Biosensor recordings demonstrated that HE is associated with a 
significant reduction in both tonic and hypoxia-induced lactate release in the cerebral 
cortex, which was normalized by OP treatment. Cortical dye loading experiments 
revealed hemichannel dysfunction in HE with improvement following OP treatment, 
while the expression of key connexins was unaffected. Conclusion. The results of 
the present study demonstrate that HE is associated with CNS hemichannel 
dysfunction, with ammonia playing a key role. The data provide evidence of a 
potential neuronal energy deficit due to impaired hemichannel-mediated lactate 
transport between astrocytes and neurons as a possible mechanism underlying 
pathogenesis of HE.    
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Hepatic encephalopathy (HE) is a serious neuropsychiatric complication associated 
with liver dysfunction, diagnosed when other known brain disorders are excluded(1). 
HE comprises a range of symptoms including sleep disturbances, alterations in 
cognitive, behavioural, fine motor and psychomotor functions, with coma and death 
occurring at the late stages(2). Several hypotheses regarding the pathogenesis of 
HE have been proposed and numerous factors have been suggested as key players 
in HE, including: inflammation(3), oxidative stress(4), impaired brain energy 
metabolism(5) and (the most common one) the neurotoxic effects of ammonia(6).  
 
Recent evidence demonstrated that astroglial lactate production and release in 
cortical cultures and in the somatosensory cortex of anesthetised rats is facilitated in 
the presence of ammonia(7). This appears to be due to acidification of the 
mitochondrial matrix resulting in a direct inhibition of mitochondrial pyruvate uptake. 
Increased brain lactate levels have also been reported in hyperammonemic 
conditions such as in acute liver failure (ALF), which is thought to be due to inhibition 
of the tricarboxylic acid cycle enzyme α-ketoglutarate dehydrogenase, suggesting a 
reduction in oxidative metabolism (8). It remains unknown whether significant 
changes in brain lactate metabolism develop in conditions of long-term CNS 
exposure to increased ammonia concentration, such as that seen during chronic liver 
disease (CLD) or HE.  
 
Astrocytes, the most numerous type of glial cell in the CNS, are thought to play an 
important role in HE pathogenesis. The astrocytic dysfunction developing during the 
progression of the disease could precipitate neuronal pathology, leading to 
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neurological impairment. Astrocytes are extensively connected by gap junctions 
formed of connexins, which also exist as functional hemichannels allowing effective 
transfer of ions, metabolic substrates and signaling molecules across the plasma 
membrane(9). Under normal physiological conditions, hemichannels are either 
closed(10) or in a flickering state(11). In certain pathological conditions, such as 
epilepsy and ischaemia, significant changes in astroglial structure and function may 
occur, which are associated with changes in connexin hemichannel function, 
affecting coupling within the astroglial networks and their communication with other 
brain cells(12). We hypothesised, therefore, that in HE, connexin hemichannel 
dysfunction contributes to the development of its neurological features. 
 
There is recent evidence that hemichannels may function as a conduit of lactate 
transport across the membrane(13). In this study we first investigated whether 
connexin hemichannel expression and hemichannel-mediated release of lactate are 
altered in animal models of HE. Ornithine phenylacetate (OP, OCR-002; Ocera 
Therapeutics, CA, USA) has been shown to reduce ammonia levels in animal 
models of cirrhosis and ALF. OP treatment was found to be associated with a 
significant reduction in the severity of brain swelling(14), improvement in 
neurophysiological function(15) and reduction in intracranial pressure(16). Therefore, 
we applied OP in this study as an experimental ammonia-lowering treatment. The 
data obtained demonstrate that, in HE, ammonia mediates cortical hemichannel 
dysfunction associated with a significant reduction in hemichannel-mediated lactate 
release.  
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Materials and Methods 
All the experiments were performed in accordance with the Animals (Scientific 
Procedures) Act 1986 (ASPA) revised according to the European Directive 
2010/63/EU. All animals received humane care according to the criteria outlined in 
the “Guide for the Care and Use of Laboratory Animals” prepared by the National 
Academy of Sciences and published by the National Institutes of Health (NIH 
publication 86-23 revised 1985). 
 
Animal models  
Male Sprague-Dawley rats (body weight ~350-400g) were obtained from a 
commercial supplier (Charles Rivers Laboratories, Inc.). 
 
Bile duct ligation (BDL) surgery: Under general anaesthesia (5% isoflurane in 100% 
oxygen for induction, 2% isofluorane in air for maintenance) 30 rats underwent triple 
ligation of the bile duct via a small laparotomy to induce chronic liver injury and were 
studied 28 days after the surgery (17). 
 
Non-cirrhotic hyperammonemia condition: 32 rats were administered high 
ammoniagenic diet (HA). The amino acid recipe used for a stock of ~100g was: 15g 
leucine, 7.7g phenylalanine, 7g glutamate, 10g alanine, 4.4g proline, 5.8g threonine, 
11g aspartate, 5g serine, 4.8g glycine, 3.3g arginine, 9.6g lysine, 8.4g histidine, 3g 
tyrosine, 1.5g tryptophan and 10.6g valine. 25 g of this mix (mixed 1:5 with standard 
rodent chow powder) was freshly prepared daily with water in a mash form and rats 
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were given free access to it for 5 days. The recipe approximates the amino acid 
composition of a rodent haemoglobin(18), mimicking the effect of gastrointestinal 
bleeding, which is a known to result in systemic hyperammonemia (19). 
 
Ornithine Phenylacetate (OP) treatment: 3 weeks after the surgery, 24 BDL-operated 
rats were given twice daily intraperitoneal injections of combined L-ornithine and 
phenylacetate (0.3g/kg; OP) ~7 hours apart for 5 days – a dosing regimen that has 
previously been shown to effectively reduce plasma ammonia concentration(20). The 
rats were studied on day 28 post BDL surgery, within 3 hours of the last OP injection. 
 
Blood and brain tissue were collected under terminal isoflurane anaesthesia. Plasma 
biochemistry was performed using a Cobas Integra II system (Roche Diagnostics). 
 
In vitro slice preparation 
Rats were humanely sacrificed by isoflurane inhalation overdose. After cardiac 
perfusion with chilled (4°C) artificial cerebrospinal fluid (aCSF, 124mM NaCl, 
3mM KCl, 2mM CaCl2, 26mM NaHCO3, 1.25mM NaH2PO4, 1mM MgSO4, 10mM D-
glucose saturated with 95% O2, 5% CO2, pH 7.5, PCO2 35 mmHg), with an 
additional 9mM Mg2+, the brain was rapidly removed and placed in a bath of chilled 
(4-6°C) aCSF. 300 µm coronal cortical slices were cut using a vibrating microtome. 
The slices were recovered in oxygenated (95% O2, 5% CO2) aCSF at room 
temperature for 30 min.  
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Western blot  
Proteins (30 µg) extracted from the cortices of 5 sham-operated, 6 BDL, 6 HA and 5 
BDL-OP-treated rats were separated by sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis on a 4% to 12% Bis-Tris NuPAGE gel (Invitrogen) and transferred to 
nitrocellulose membranes. Membranes were blocked with 5% Bovine Serum 
Albumin and incubated with antibodies against connexin-43 (Cell Signaling 
Technology, 1:1000), connexin-36 (Santa Cruz, 1:1000), connexin-30 (Invitrogen, 1 
µg/mL) and connexin-26 (Thermo Fisher Scientific, 1 µg/mL). Detection of actin 
(Santa Cruz, 1:1000) was used to control for protein loading. Binding of antibody was 
detected using a horseradish peroxidase-conjugated secondary antibody (Goat anti-
rabbit or goat anti-mouse IgG-HPR, Santa Cruz, 1:10000) where appropriate and the 
SuperSignal Chemiluminescence Substrate for detection of horseradish peroxidase 
(Pierce). Densitometric analysis was performed using Kodak 1D image analysis 
software (Kodak, Rochester, NY). 
 
Measurements of lactate release using microelectrode biosensors  
Amperometric enzymatic biosensors were obtained from Sarissa Biomedical 
(Coventry, UK). The design and operation of the biosensors were described in detail 
previously (21, 22). All sensors were operating against a reference electrode 
(Ag/AgCl) and had a linear response to lactate within the concentration range 
recorded in this study (22, 23). Further information on the principle of operation and 
response time is given in the online data supplement (Supplementary Figure 1A-C). 
To control for the release of non-specific electroactive interferants, a dual recording 
configuration was used. In every recording, a “null” sensor, lacking enzymes but 
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otherwise identical, was used to measure current changes not associated with 
lactate oxidase activity, which were then subtracted from the current recorded by the 
lactate biosensor (24) (Figure 1).  
 
The sensors were calibrated directly in the slice chamber immediately before and 
after every recording by application of 100 µM of lactate (Figure 1). To convert 
changes in the biosensor current to changes in lactate concentration, an average of 
sensor calibrations before and after the recording were used. For each of the 
recordings, a slice was transferred into the recording chamber and superfused with 
aCSF at 35°C (3 ml min-1). Sensors were initially placed in the chamber having no 
contact with the brain slice. Once a steady-state baseline was achieved, the sensors 
were laid flat in direct contact with the surface of the slice (Figure 1), revealing tonic 
lactate release which stabilised within ~15 min. Hypoxic conditions, known to 
increase both lactate production due to inhibition of oxidative phosphorylation and 
the opening probability of astroglial connexin hemichannels (23, 25), were induced 
for 2-4 min by replacement of oxygen in the medium with nitrogen (perfusion of the 
chamber with aCSF saturated with 95% N2/5% CO2)(26, 27). As detection of lactate 
by the biosensors requires oxygen (Supplementary Figure 1B) (28), the effect of 
hypoxia was determined by measuring the peak lactate release upon re-oxygenation 
(Figure 1) as described in detail previously(23, 28). Once the baseline was restored, 
Ca2+-free aCSF (with the addition of 1 mM EGTA) was applied for 20 min as the 
second stimulus known to increase the opening probability of certain membrane 
channels, including connexin hemichannels(29). There is no prior evidence that Ca2+ 
- mediated increases in mitochondrial NADH influence cytosolic NAD+/NADH 
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homeostasis and therefore lactate production(30). These stimuli were reapplied in 
the presence of connexin hemichannel blockers carbenoxolone (CBX, 100 µM; 
Sigma) or 5-Nitro-2-(3-phenylpropylamino)benzoic acid (NPPB, 200 µM, Sigma). 
CBX and NPPB were previously shown to have no effect on lactate biosensor 
detection system(23).  
 
Assessment of hemichannel function by dye loading 
For the assessment of hemichannel functionality (effectiveness of channel opening 
and closing) we used a fluorescent dye carboxyfluorescein (CBF: 376 Da). Connexin 
hemichannels are permeable to CBF and can act as conduits of CBF transfer across 
the membrane in accord with the concentration gradient of the dye. Cortical slices 
from sham-operated, BDL, HA and BDL-OP-treated rats were exposed to control 
aCSF with an addition of CBF (200 µM) for 9 min resulting in background connexin-
mediated dye loading (Figure 5A-B), followed by perfusion with Ca2+-free aCSF 
without CBF for 9 min resulting in CBF unloading. Ca2+-free aCSF with CBF was 
then applied for 4 min increasing the permeability of hemichannels and therefore 
resulting in dye loading. Hypoxic conditions (without CBF) were next applied to 
unload the slice and also to demonstrate bidirectional permeability of the channel to 
CBF(27). The same hypoxic stimulus was then re-applied in the presence of CBF, 
resulting in dye loading. After application of each stimulus in the presence of CBF, a 
further 5 min perfusion with aCSF containing CBF, followed by a 10 min wash with 
normal aCSF was applied, enabling the channels to return to their physiological 
state. Images were taken using MiCAM-02 imaging system (SciMedia). Using 
ImageJ software, regions of interest (ROI) were drawn around an area of the 
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cerebral cortex (~3cm2) across layers I-III and the mean pixel intensities for the ROI 
were calculated. Background fluorescence was subtracted.  
 
Statistical analysis  
Western blot data were normalised using the protocol of LI-COR Biosciences 
(Normalization Accuracy for Western Blotting) and group data were compared using 
two-way ANOVA with Tukey post hoc test. Data obtained using biosensor recordings 
were analysed and presented non-parametrically using box and whisker plots 
(Figures 2A, 3A, 4A). For the comparisons between the experimental groups, Mann 
Whitney U test was applied. The peak hypoxia- or 0 Ca2+-induced lactate releases 
are presented as changes in release from the baseline (Figure 1). The effects of 
connexin blockers are presented as % changes from the control responses recorded 
in the absence of the blockers and Wilcoxon signed rank test was applied for 
comparison. P values in Figures 2-4B,C indicate significance level of differences 
between the control responses and the responses recorded in the presence of the 
drugs. 
 
Data obtained in dye loading experiments were analysed using two-way ANOVA 
(Figure 5B, data normally distributed) followed by Tukey post hoc test or Wilcoxon 
signed rank test (Figures 5C-D, data not normally distributed), as appropriate. The 
biochemistry data was analysed using one-way ANOVA. Data are reported as 
mean±SEM. Differences with p value of <0.05 were considered to be significant. In 
all the experiments the ‘n’ number represents the number of animals. Sample sizes 
were calculated using Gpower 3 v3.1.9.2 (http://www.gpower.hhu.de/en.html)(31); 
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using a ‘means: Wilcoxon-Mann-Whitney test (two groups)’ test, with a desired 
power of 90% and a significance level of 5%. The effect size varied between groups 
according to the preliminary data acquired during the study. Statistical analysis was 
performed using OriginPro 9.1 (OriginLab). 
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Results 
Biochemistry 
Plasma biochemistry and ammonia concentration was assessed in all groups of 
animals (Supplementary Table 1). Compared to sham surgery, BDL resulted in a 
significant increase in plasma ALT and bilirubin (p<0.001), indicating impaired liver 
function, while albumin and total protein concentrations were significantly decreased 
(p<0.001). Treatment of BDL rats with OP had no effect on these parameters. Rats 
fed with HA diet had similar plasma biochemistry to control rats. 
 
Plasma ammonia concentrations were significantly higher in BDL and HA rats when 
compared to sham-operated animals (p<0.001). Treatment of BDL animals with OP 
lowered plasma ammonia concentration, which was similar to that measured in 
sham-operated animals (p=0.3) (Supplementary Table 1). 
 
Release of lactate in the cerebral cortex in animal models of HE  
In cortical slices of sham-operated animals, enzymatic amperometric biosensors 
detected tonic lactate efflux of 335±10 µM (n=18). Recordings from cortical slices of 
BDL and HA rats showed lower tonic release of lactate of 203±6 µM (p=0.03, n=18) 
and 178±8 µM (p=0.005, n=16), respectively (Figure 2A). Increasing the permeability 
of connexin hemichannels by lowering [Ca2+]e (0 Ca
2+ conditions) triggered similar 
increases in the release of lactate in sham-operated rats (by 43±3µM, n=15), BDL 
(by 38±4 µM; p=0.07, n=17) and HA animals (by 54±4 µM; p=0.5, n=16) (Figure 3A). 
Hypoxia facilitated release of lactate in cortical slices of sham-operated rats (43±3 
µM, n=18), but had no effect on lactate release in slices of BDL (1±0.8 µM; p<0.001, 
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n=18) and HA animals (5±2 µM; p<0.001, n=16) (Figure 4A). These results 
demonstrated impaired tonic and hypoxia-induced release of lactate in both animal 
models of HE. 
 
Ammonia lowering treatment restores cortical lactate release  
Daily OP treatments had been shown to decrease systemic and brain ammonia 
concentrations in BDL animals(20). We next found that in our experiments, OP 
treatment of BDL rats restored tonic (374±11 µM; p=0.4, n=14) and hypoxia-induced 
(32±3 µM; p=0.6, n=14) lactate release similar to that recorded in cortical slices of 
sham-operated animals (Figure 2A-4A). Direct application of OP on cortical slices of 
sham-operated and BDL rats had no effect on lactate release (Supplementary Figure 
1D). These results strongly suggest that high ammonia levels are responsible for the 
reduction in lactate release in the cerebral cortex of BDL animals. 
 
Impaired hemichannel function underlies reduced cortical lactate release in 
animal models of HE 
In cortical slices of sham-operated animals, application of hemichannel blockers 
CBX (n=9) or NPPB (n=9) resulted in a significant reduction in lactate tone (Figure 
2B-C). Hemichannel blockade had no effect on lactate tone in cortical slices of BDL 
animals (Figure 2B-C). However, hemichannel blockade had an effect on lactate 
tone recorded in cortical slices of HA animals (CBX: n=10; NPPB: n=8) (Figure 2B-
C). CBX and NPPB reduced lactate tone in cortical slices of BDL animals treated 
with OP (CBX: n=10; NPPB: n=10) (Figure 2B-C). 
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In cortical slices of sham-operated (CBX: n=8; NPPB: n=6) and HA animals (CBX: 
n=10; NPPB: n=8), hemichannel blockade using CBX or NPPB abolished or 
significantly reduced the amount of lactate release facilitated in Ca2+-free conditions 
(Figure 3B-C). Smaller effect of hemichannel blockers on 0 Ca2+-induced release of 
lactate was observed in cortical slices of BDL rats (CBX: n=11; NPPB: n=9) (Figure 
3B-C). In conditions of OP treatment, when basal and evoked lactate release were 
restored in cortical slices of BDL rats, CBX (n=7) and NPPB (n=7) abolished the 
release of lactate triggered by 0 Ca2+ (CBX: n=7; NPPB: n=7); an effect similar to 
that observed after application of hemichannel blockers in cortical slices of sham-
operated animals (Figure 3B-C). 
 
Hypoxia-induced release of lactate recorded in cortical slices of sham-operated 
animals was also abolished or dramatically reduced by connexin blockade (CBX: 
n=9; NPPB: n=7) (Figure 4B-C). CBX and NPPB had no significant effect on the 
release of lactate induced by hypoxia in cortical slices of BDL (CBX: n=13; NPPB: 
n=9) and HA rats (CBX: n=10; NPPB: n=12) (Figure 4B-C). In cortical slices of OP-
treated BDL rats, the effects of CBX and NPPB were restored. CBX (n=8) and NPPB 
(n=7) effectively abolished hypoxia-induced lactate release in cortical slices of BDL 
rats treated with OP (Figure 4B-C).  
 
Application of MCT blocker, α-Cyano-4-hydroxycinnamic acid (4-CIN) had no 
significant effect on tonic release of lactate in cortical slices of sham-operated (n=5) 
and BDL rats (n=5) (Supplementary Figure 2A-B). Hypoxia-induced lactate release 
recorded in sham-operated rats (n=5) was significantly reduced by 4-CIN, as 
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reported previously(13). In cortical slices of BDL rats (n=5) the effect of 4-CIN on 
hypoxia-induced release of lactate was found to be smaller (Supplementary Figure 
2A-B). 
 
These results demonstrate that connexin hemichannel blockade has no effect on the 
release of lactate in the cerebral cortex of BDL rats. This implies that the function of 
hemichannels, which act as conduits of lactate release(23), is already compromised 
in the brains of these animals. These data also suggest that cortical hemichannel 
dysfunction in the BDL animals is likely to be due to the actions of ammonia. 
 
Hemichannel-mediated dye loading in animal models of HE  
Membrane channel-mediated dye loading experiments were next performed in 
cortical slices to confirm hemichannel dysfunction in HE.  
 
In cortical slices of sham-operated rats (n=10), significant background loading 
(14.3±0.4 A.U) was observed in control conditions when slices were perfused with 
aCSF containing CBF (Figure 5A-B). Increasing the permeability of hemichannels by 
lowering [Ca2+]e in the absence of CBF reduced slice fluorescence by 6.4±0.2 A.U. 
The same stimulus applied in the presence of CBF significantly increased 
fluorescence by 16.9±0.6 A.U. Hypoxia-induced opening of hemichannels in the 
absence of CBF resulted in dye unloading with fluorescence decreasing by 12.7±0.4 
A.U. Addition of CBF in conditions of hypoxia increased slice fluorescence by 
13.9±0.4 A.U (Figure 5B).  
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Cortical slices from HA rats (n=10) displayed background loading (Figure 5A-B) and 
0 Ca2+ -induced unloading of 11.2±0.2 A.U (p=0.04) and 4.7±0.08 A.U (p=0.4) 
respectively (Figure 5B). Addition of CBF in 0 Ca2+ conditions increased fluorescence 
by 11.6±0.2 A.U (p=0.004), similar to that observed in slices of sham-operated 
animals. However, the effect of hypoxia was significantly reduced in slices of HA 
animals (unloading by 7.6±0.1 A.U, p<0.001; loading by 7.8±0.2 A.U, p<0.001) 
(Figure 5B). 
 
In cortical slices of BDL rats (n=10) efficacy of CBF dye loading and unloading was 
markedly reduced under all the conditions (Figure 5A-B). In cortical slices of BDL 
animals treated with OP, hemichannel-mediated CBF dye loading and unloading 
were similar to that observed in slices of sham-operated animals (Figure 5A-B).  
 
Hemichannel blockade with CBX or NPPB effectively abolished CBF dye loading and 
unloading in cortical slices of sham-operated animals (Figure 5C-D). In cortical slices 
of BDL and HA rats, CBX and NPPB had no significant effect on dye loading and 
unloading (Figure 5C-D). In cortical slices of OP-treated BDL rats, the effects of CBX 
and NPPB on CBF dye loading and unloading were similar to that observed in sham-
operated animals. (Figure 5C-D). Figures 5C-D illustrate changes in fluorescence 
(∆Fluorescence) following application of the hemichannel blockers, compared to the 
respective changes in fluorescence recorded in the absence of blockers in slices of 
the same animal. Negative values show decreases in fluorescence while positive 
values illustrate higher fluorescence levels compared to the controls. 
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These data show that the background activity and stimuli-evoked opening and 
closure of connexin hemichannels is impaired in BDL and HA rats. The efficacy of 
CBF dye loading is restored by OP treatment of BDL animals suggesting that the 
actions of ammonia are responsible for cortical hemichannel dysfunction in HE. 
 
Cortical connexin expression in animal models of HE 
We next evaluated the expression of main astrocytic and neuronal connexins in 
animal models of HE used in this study. Western blots were performed on proteins 
extracted from the cerebral cortices of sham-operated, BDL, HA and BDL-OP 
animals Figure 6). No differences in cortical connexin-43, connexin-36 and connexin-
30 expression was observed between sham-operated, BDL, HA and OP-treated BDL 
animals. An increase in connexin-26 expression (p=0.03) was observed in BDL-OP 
rats compared to the BDL animals (Figure 6). Expression of MCT-1 was similar in all 
the experimental groups (Supplementary Figure 2C) 
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Discussion 
Brain information processing requires constant and sufficient supply of oxygen and 
metabolic substrates. Astrocytes represent an important source of lactate which 
contributes to the extracellular pool of readily available metabolic substrates taken 
up by neurons to fuel their activity(32). While previously, lactate transport across the 
cell membranes was thought to be achieved solely via operation of monocarboxylate 
transporters (MCTs), a recent study(23) demonstrated the role of connexin 
hemichannels as equally important conduits of lactate release.  
 
In animal models of ALF and patients, an increase in brain lactate concentration has 
consistently been reported(33). Concentrations of lactate in the cerebrospinal fluid 
were also found to be elevated in cirrhotic patients but only in severe cases of 
HE(34). The BDL and HA rats used in our experiments are models of minimal 
HE(35). In contrast to the existing evidence suggesting that brain lactate 
concentrations are increased in patients with ALF(36), our experiments 
demonstrated that the development of HE in rats is associated with a significant 
reduction in tonic and stimulated release of lactate in the cerebral cortex. Blockade 
of connexin hemichannels was found to be effective in reducing lactate release in 
sham-operated and HA animals but was ineffective in BDL rats, suggesting that the 
reduction in hemichannel-mediated lactate release in BDL animals is due to a 
combination of pathological factors (e.g. inflammation, oxidative stress).   
 
Increased lactate production by astrocytes appears to be essential for the recovery 
of synaptic function during re-oxygenation after hypoxia(37). We found that hypoxia-
Page 20 of 44
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
21 
 
induced lactate release was significantly lower in the cerebral cortex of BDL and HA 
rats compared to control animals and this was unaffected by the hemichannel 
blockers indicating hemichannel dysfunction. The observed decrease in extracellular 
lactate is likely due to impaired release from astrocytes although increased neuronal 
activity and therefore lactate consumption cannot be excluded. The observation of 
Bosoi et al.,(38) showing higher total brain lactate of BDL rats using NMR 
spectroscopy seems to contradict our data. Bosoi and colleagues suggested that 
increased lactate contributes to the pathogenesis of brain edema (cytotoxic), and 
may imply that the observed increase in total brain lactate is due to its intracellular 
accumulation. If the rate of lactate production and glymphatic clearance (39) are not 
affected, intracellular retention of lactate would explain higher concentration of this 
metabolite as measured by NMR spectroscopy (40) and would be in full agreement 
with our data showing impairment of hemichannel-mediated release in HE.   
 
High concentration of ammonia can potentially generate significant pH changes, 
which can have various effects on many pH sensitive membrane channels, including 
hemichannels. The pH sensitivity of hemichannels is known as the chemical gate, 
which is the phenomenon of hemichannel blockade when intracellular pH (pHi) 
decreases(40). This provides one potential mechanism which might be responsible 
for impaired hemichannel-mediated lactate release in HE.  
 
We also examined hemichannel functionality using the dye loading method. Some 
differences between the data obtained using biosensor recordings and this technique 
could be due to the fact that CBF is not identical to the molecular structure and size 
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of lactate. Additionally, lactate could be released through specific connexin 
hemichannels, whereas CBF is small enough to pass through the majority of 
hemichannels expressed by both astrocytes and neurons. While induction of hypoxia 
targets predominantly astroglial hemichannels, the rest of the conditions are not cell 
specific and conclusions on affected cell types cannot be drawn from the results 
obtained using dye loading experiments.  
 
The experimental stimuli used (0 Ca2+ and hypoxia) are known to increase the 
permeability of hemichannels, possibly by affecting various protein bonds resulting in 
conformational changes(29). Dye loading experiments clearly demonstrated a 
marked reduction in fluorescent dye uptake and release in cortical slices of BDL and 
HA rats compared to sham-operated animals (the differences were more profound 
when hypoxia was used as a stimulus), suggesting reduced bidirectional 
permeability of hemichannels in these animal models of HE. Hemichannel blockade 
had no effect on fluorescent dye uptake in BDL and HA rats providing additional 
evidence that the function of these channels is already compromised in HE. 
Ammonium ions may cause structural alterations to the connexin proteins, by 
interacting with various amino acid side chains, which could affect gating of the 
channel. However, since hemichannels have a relatively short life cycle and recycled 
frequently, the observed changes in hemichannel functionality appear to be 
reversible with OP treatment.  
 
In CLD, hyperammonemia is believed to impair mitochondrial function and induce 
astroglial dysfunction, which is associated with altered neurotransmitter recycling 
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leading to neuronal damage(41). Ammonia may also interfere with cell energy 
metabolism in several ways. There is recent evidence that in astrocytes ammonia 
may divert the flux of pyruvate to lactate production, contributing to the net aerobic 
lactate production(7). However, the effects of chronic ammonia exposure on 
astrocytes are unknown. We investigated the role of ammonia by treating BDL rats 
with OP, a drug known to lower systemic and brain ammonia(20). OP treatment 
improved the neurochemical phenotype of BDL animals by restoring the tonic and 
stimulated connexin hemichannel-mediated lactate release. Furthermore, 
hemichannel blockade became effective following OP treatment, suggesting that 
ammonia is indeed responsible for hemichannel dysfunction observed in this model. 
 
Cytotoxic brain edema observed in BDL animals is attenuated by ammonia-lowering 
treatments such as the one used in this study(20, 42). The effect of cell swelling on 
hemichannel function is poorly understood. Ye et al.,(43) showed that astrocytes 
obtained from connexin-43 knock-out animals developed cell swelling as efficiently 
as the wild type animals when exposed to a hypotonic solution suggesting that 
hemichannels do not play a significant role in this process although evidence to the 
contrary exists (44).  
 
We also examined the expression profile of key astroglial and neuronal connexins in 
the animal models of HE used in this study. No significant differences in connexin 
hemichannel protein expression profile were observed suggesting that HE is 
associated with altered hemichannel function but not with changes in connexin 
expression. The upregulated expression of connexin-26 observed in the BDL-OP 
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animals is not prominent enough to explain the marked improvement observed in the 
lactate measurements and dye loading experiments. Additionally, we did not observe 
any changes in the expression of the main astroglial lactate transporter MCT-1 in the 
models of HE used in this study. No effect of 4-CIN, a MCT blocker, on lactate 
release was observed in cortical slices of sham-operated and BDL animals. Hypoxia-
induced lactate release in sham-operated rats was significantly reduced by the 
application of 4-CIN, as demonstrated in the previous study (23). 
 
Depletion of lactate as one of the key readily available metabolic substrates may 
have important neurological consequences particularly in patients with advanced 
cirrhosis given the fact that these patients display evidence of cerebral 
vasoconstriction(45), which is associated with impaired cerebral autoregulation, an 
important mechanism which ensures constant cerebral blood flow (46). Clinical 
consequences of this may be relevant during liver transplantation, where further 
reductions in cerebral blood flow have been observed during the anhepatic phase of 
transplantation and may contribute to post-transplant neurologic dysfunction(47). 
Evidence for critical reduction in cerebral oxygenation was obtained in the majority of 
patients with acute-on-chronic liver failure who had poor neurologic outcome 
supporting the hypothesis that the brain energy metabolism is critically compromised 
in cirrhosis and further perturbations as demonstrated in this paper may be clinically 
deleterious(48). Our data indicating an impaired hemichannel-mediated lactate 
release during tissue hypoxia, in combination with these observations could help to 
explain the severe neurological manifestations in patients with HE. As ammonia is 
central in causing this dysfunction, the potential clinical implications involve the use 
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of ammonia lowering treatments as the main therapeutic strategy, as well as 
attempts to increase cerebral oxygenation in order to preserve the neuronal function. 
 
In conclusion, the results of the present study suggest that HE is associated with 
CNS hemichannel dysfunction, with ammonia playing a key role. The data provide 
evidence of a potential neuronal energy deficit due to impaired hemichannel-
mediated lactate transport between astrocytes and neurons as a possible 
mechanism underlying pathogenesis of HE.   
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LEGENDS TO FIGURES 
Figure 1: Measuring release of lactate using microelectrode biosensors. 
Representative example of changes in the net lactate biosensor current 
(difference in current between lactate and null sensors) during calibration (100 
µM lactate), after biosensor placement in a direct contact with the surface of 
the cortical slice (recording tonic lactate release), in response to a hypoxic 
challenge (perfusion with aCSF saturated with 95% N2/5% CO2), and in 
response to lowering extracellular [Ca2+]. Peak hypoxia-induced lactate 
release is measured upon re-oxygenation. Inset: Schematic drawing of the 
dual recording configuration of lactate and null (control) biosensors placed on 
the surface of the slice. 
 
Figure 2: HE is associated with a reduction in hemichannel-mediated 
tonic release of lactate in the cerebral cortex. A) Summary data illustrating 
tonic release of lactate in cortical slices of sham-operated, BDL, HA and BDL-
OP treated rats. p values indicate differences from sham-operated group. B) 
Left: Summary data illustrating the effect of hemichannel blocker 
carbenoxolone (CBX, 100 µM) on tonic release of lactate (expressed as % 
change from the baseline) in cortical slices of sham-operated, BDL, HA and 
BDL-OP treated rats. Right: Representative recordings of lactate biosensor 
current showing changes in tonic release of lactate in response to CBX 
application. p values indicate the level of significant differences from the 
respective baseline. C) Left: Summary data illustrating the effect of 5-Nitro-2-
(3-phenylpropylamino) benzoic acid (NPPB, 200 µM) on tonic release of 
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lactate (expressed as % change from the baseline) in cortical slices of sham-
operated, BDL, HA and BDL-OP treated rats. Right: Representative 
recordings of lactate biosensor current showing changes in tonic release of 
lactate in response to NPPB application. p values indicate the level of 
significant differences from the respective baseline.  
 
Figure 3: HE is associated with a reduction of lactate release in 
response to lowering extracellular [Ca2+], which promotes hemichannel 
opening. A) Summary data illustrating peak changes in lactate release in 
response to lowering [Ca2+]e in cortical slices of sham-operated, BDL, HA and 
BDL-OP-treated rats. p values indicate differences from the responses in 
sham-operated animals. B) Left: Summary data illustrating the effect of CBX 
(100 µM) on the release of lactate facilitated in response to 0 [Ca2+]e 
(expressed as the % of the amount of lactate released in response to 0 
[Ca2+]e in the absence of CBX) in cortical slices of sham-operated, BDL, HA 
and BDL-OP treated rats. Right: Representative recordings of lactate 
biosensor current showing the effect of CBX on 0 [Ca2+]e -induced release of 
lactate. p values indicate differences between the responses recorded in the 
absence and presence of CBX. C) Left: Summary data illustrating the effect of 
NPPB (200 µM) on the release of lactate facilitated in response to 0 [Ca2+]e 
(expressed as the % of the amount of lactate released in response to 0 
[Ca2+]e in the absence of NPPB) in cortical slices of sham-operated, BDL, HA 
and BDL-OP treated rats. Right: Representative recordings of lactate 
biosensor current showing the effect of NPPB on 0 [Ca2+]e -induced release of 
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lactate. p values indicate differences between the responses recorded in the 
absence and presence of NPPB. 
 
Figure 4: HE is associated with a reduction of hypoxia-induced release 
of lactate. A) Summary data illustrating peak changes in lactate release in 
response to hypoxia (aCSF saturated with 95% N2/5% CO2) in cortical slices 
of sham-operated, BDL, HA and BDL-OP-treated rats. p values indicate 
differences from the responses in sham-operated animals. B) Left: Summary 
data illustrating the effect of CBX (100 µM) on the release of lactate facilitated 
in response to tissue hypoxia (expressed as the % of the amount of lactate 
released in response to hypoxia in the absence of CBX) in cortical slices of 
sham-operated, BDL, HA and BDL-OP treated rats. Right: Representative 
recordings of lactate biosensor current showing the effect of CBX on hypoxia-
induced release of lactate. Decrease in O2 availability reduces biosensor 
current followed by a positive signal upon re-oxygenation, which is used to 
estimate hypoxia-induced lactate release. p values indicate differences 
between the responses recorded the absence and presence of CBX. C) Left: 
Summary data illustrating the effect of NPPB (200 µM) on the release of 
lactate facilitated in response to hypoxia (expressed as the % of the amount 
of lactate released in response to hypoxia in the absence of NPPB) in cortical 
slices of sham-operated, BDL, HA and BDL-OP-treated rats. Right: 
Representative recordings of lactate biosensor current showing the effect of 
NPPB on the hypoxia-induced release of lactate. p values indicate differences 
between the responses recorded in the absence and presence of NPPB. 
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 Figure 5: Impaired hemichannel-mediated dye loading reveals cortical 
hemichannel dysfunction in HE. A) Representative images of background 
loading with carboxyfluorescein (CBF) dye in cortical slices of sham-operated, 
BDL, HA and BDL-OP-treated rats. White dashed line depicts the edge of the 
cortical slice. B) Fluorescence intensity changes in cortical slices of sham-
operated, BDL, HA and BDL-OP treated rats in response to 0 [Ca2+]e and 
hypoxia in the absence and presence of CBF in the medium. Application of 0 
[Ca2+]e aCSF or hypoxia in the presence of CBF results in dye loading and 
increase in fluorescence, while application of these stimuli in the absence of 
CBF results in dye unloading and decrease in fluorescence. Insets: Schematic 
drawings of connexin hemichannel mediated dye loading and unloading. * 
p<0.05, **p<0.001 significant differences from the sham-operated group. C) 
Summary data illustrating the effect of CBX (100 µM) on fluorescence 
intensity changes (∆Fluorescence) in cortical slices of sham-operated, BDL, 
HA and BDL-OP treated rats induced by 0 [Ca2+]e and hypoxia in the absence 
and presence of CBF in the medium. The data are presented as differences in 
fluorescence following CBX application compared to the respective 
fluorescence recorded in the absence of CBX. * p<0.05 significant effect of 
CBX on CBF loading and unloading. D) Summary data illustrating the effect of 
NPPB (200 µM) on fluorescence intensity changes (∆Fluorescence) in cortical 
slices of sham-operated, BDL, HA and BDL-OP treated rats induced by 0 
[Ca2+]e and hypoxia in the absence and presence of CBF in the medium. The 
data are presented as differences in fluorescence following NPPB application 
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compared to the respective fluorescence recorded in the absence of NPPB. * 
p<0.05 significant effect of NPPB on CBF loading and unloading. 
 
Figure 6: Cortical connexin expression is not affected in HE. Summary 
data illustrating means ± SE of the densitometry of connexin-43, connexin-36, 
connexin-30 and connexin-26 protein expression normalized to the 
expression of Actin, in cell lysates of the cerebral cortices of sham-operated, 
BDL, HA and BDL-OP treated rats. Bottom: Representative immunoblots 
showing connexin-43, connexin-36, connexin-30 and connexin-26 protein 
expression in cerebral cortices of sham-operated, BDL, HA and BDL-OP 
treated rats. p value indicates difference in expression level between BDL and 
BDL-OP groups. 
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Figure 1: Measuring release of lactate using microelectrode biosensors. Representative example of 
changes in the net lactate biosensor current (difference in current between lactate and null sensors) during 
calibration (100 µM lactate), after biosensor placement in a direct contact with the surface of the cortical 
slice (recording tonic lactate release), in response to a hypoxic challenge (perfusion with aCSF saturated 
with 95% N2/5% CO2), and in response to lowering extracellular [Ca
2+]. Peak hypoxia-induced lactate 
release is measured upon re-oxygenation. Inset: Schematic drawing of the dual recording configuration of 
lactate and null (control) biosensors placed on the surface of the slice.  
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Figure 2: HE is associated with a reduction in hemichannel-mediated tonic release of lactate in 
the cerebral cortex. A) Summary data illustrating tonic release of lactate in cortical slices of sham-
operated, BDL, HA and BDL-OP treated rats. p values indicate differences from sham-operated group. B) 
Left: Summary data illustrating the effect of hemichannel blocker carbenoxolone (CBX, 100 µM) on tonic 
release of lactate (expressed as % change from the baseline) in cortical slices of sham-operated, BDL, HA 
and BDL-OP treated rats. Right: Representative recordings of lactate biosensor current showing changes in 
tonic release of lactate in response to CBX application. p values indicate the level of significant differences 
from the respective baseline. C) Left: Summary data illustrating the effect of 5-Nitro-2-(3-
phenylpropylamino) benzoic acid (NPPB, 200 µM) on tonic release of lactate (expressed as % change from 
the baseline) in cortical slices of sham-operated, BDL, HA and BDL-OP treated rats. Right: Representative 
recordings of lactate biosensor current showing changes in tonic release of lactate in response to NPPB 
application. p values indicate the level of significant differences from the respective baseline.  
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Figure 3: HE is associated with a reduction of lactate release in response to lowering 
extracellular [Ca2+], which promotes hemichannel opening. A) Summary data illustrating peak 
changes in lactate release in response to lowering [Ca2+]e in cortical slices of sham-operated, BDL, HA and 
BDL-OP-treated rats. p values indicate differences from the responses in sham-operated animals. B) Left: 
Summary data illustrating the effect of CBX (100 µM) on the release of lactate facilitated in response to 0 
[Ca2+]e (expressed as the % of the amount of lactate released in response to 0 [Ca
2+]e in the absence of 
CBX) in cortical slices of sham-operated, BDL, HA and BDL-OP treated rats. Right: Representative recordings 
of lactate biosensor current showing the effect of CBX on 0 [Ca2+]e -induced release of lactate. p values 
indicate differences between the responses recorded in the absence and presence of CBX. C) Left: Summary 
data illustrating the effect of NPPB (200 µM) on the release of lactate facilitated in response to 0 [Ca2+]e 
(expressed as the % of the amount of lactate released in response to 0 [Ca2+]e in the absence of NPPB) in 
cortical slices of sham-operated, BDL, HA and BDL-OP treated rats. Right: Representative recordings of 
lactate biosensor current showing the effect of NPPB on 0 [Ca2+]e -induced release of lactate. p values 
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indicate differences between the responses recorded in the absence and presence of NPPB.  
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Figure 4: HE is associated with a reduction of hypoxia-induced release of lactate. A) Summary data 
illustrating peak changes in lactate release in response to hypoxia (aCSF saturated with 95% N2/5% CO2) in 
cortical slices of sham-operated, BDL, HA and BDL-OP-treated rats. p values indicate differences from the 
responses in sham-operated animals. B) Left: Summary data illustrating the effect of CBX (100 µM) on the 
release of lactate facilitated in response to tissue hypoxia (expressed as the % of the amount of lactate 
released in response to hypoxia in the absence of CBX) in cortical slices of sham-operated, BDL, HA and 
BDL-OP treated rats. Right: Representative recordings of lactate biosensor current showing the effect of CBX 
on hypoxia-induced release of lactate. Decrease in O2 availability reduces biosensor current followed by a 
positive signal upon re-oxygenation, which is used to estimate hypoxia-induced lactate release. p values 
indicate differences between the responses recorded the absence and presence of CBX. C) Left: Summary 
data illustrating the effect of NPPB (200 µM) on the release of lactate facilitated in response to hypoxia 
(expressed as the % of the amount of lactate released in response to hypoxia in the absence of NPPB) in 
cortical slices of sham-operated, BDL, HA and BDL-OP-treated rats. Right: Representative recordings of 
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lactate biosensor current showing the effect of NPPB on the hypoxia-induced release of lactate. p values 
indicate differences between the responses recorded in the absence and presence of NPPB.  
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Figure 5: Impaired hemichannel-mediated dye loading reveals cortical hemichannel dysfunction 
in HE. A) Representative images of background loading with carboxyfluorescein (CBF) dye in cortical slices 
of sham-operated, BDL, HA and BDL-OP-treated rats. White dashed line depicts the edge of the cortical 
slice. B) Fluorescence intensity changes in cortical slices of sham-operated, BDL, HA and BDL-OP treated 
rats in response to 0 [Ca2+]e and hypoxia in the absence and presence of CBF in the medium. Application of 
0 [Ca2+]e aCSF or hypoxia in the presence of CBF results in dye loading and increase in fluorescence, while 
application of these stimuli in the absence of CBF results in dye unloading and decrease in fluorescence. 
Insets: Schematic drawings of connexin hemichannel mediated dye loading and unloading. * p<0.05, 
**p<0.001 significant differences from the sham-operated group. C) Summary data illustrating the effect of 
CBX (100 µM) on fluorescence intensity changes (∆Fluorescence) in cortical slices of sham-operated, BDL, 
HA and BDL-OP treated rats induced by 0 [Ca2+]e and hypoxia in the absence and presence of CBF in the 
medium. The data are presented as differences in fluorescence following CBX application compared to the 
respective fluorescence recorded in the absence of CBX. * p<0.05 significant effect of CBX on CBF loading 
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and unloading. D) Summary data illustrating the effect of NPPB (200 µM) on fluorescence intensity changes 
(∆Fluorescence) in cortical slices of sham-operated, BDL, HA and BDL-OP treated rats induced by 0 [Ca2+]e 
and hypoxia in the absence and presence of CBF in the medium. The data are presented as differences in 
fluorescence following NPPB application compared to the respective fluorescence recorded in the absence of 
NPPB. * p<0.05 significant effect of NPPB on CBF loading and unloading.  
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Figure 6: Cortical connexin expression is not affected in HE. Summary data illustrating means ± SE of 
the densitometry of connexin-43, connexin-36, connexin-30 and connexin-26 protein expression normalized 
to the expression of Actin, in cell lysates of the cerebral cortices of sham-operated, BDL, HA and BDL-OP 
treated rats. Bottom: Representative immunoblots showing connexin-43, connexin-36, connexin-30 and 
connexin-26 protein expression in cerebral cortices of sham-operated, BDL, HA and BDL-OP treated rats. p 
value indicates difference in expression level between BDL and BDL-OP groups.  
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SUPPLEMENTARY MATERIAL 
Supplementary Figure 1: Response time, principles of lactate biosensor 
operation and the effect of OP on lactate detection system. A) A 
schematic drawing of the lactate biosensor assembly showing the enzymatic 
biolayer, which surrounds the tip of the platinum (Pt) wire. B) Enzymatic 
reaction taking place in the biolayer of the sensor. C) Expanded portion of the 
lactate calibration trace illustrating the response characteristics of the lactate 
biosensor. Note that the sensor responds immediately when lactate solution is 
starting to enter the calibration chamber. D) Raw traces illustrating lactate 
biosensor current responses to lactate (100 µM) when calibrated in control 
artificial cerebrospinal fluid (aCSF), and in the presence of ornithine 
phenylacetate (OP, 1:50 dilution of the stock solution of 0.1g/ml; concentration 
applied is similar to the concentration estimated to be reached in a 300 g rat 
following IP injections). Bottom: Representative trace from the recordings 
obtained in the cerebral cortex of a BDL rat showing the effect of OP on 
lactate tone. Grey shading indicates period of drug application. 
 
Supplementary Figure 2: Monocarboxylate transporter (MCT) protein 
expression and functionality in cortical slices of sham-operated and 
BDL rats. A) Summary data illustrating the effect of MCT blocker, 4-CIN (250 
Μm, Sigma) on tonic release of lactate (expressed as % change from the 
baseline) and release of lactate facilitated in response to tissue hypoxia and 0 
[Ca2+]e (expressed as the % of the amount of lactate released in response to 
hypoxia/0 [Ca2+]e in the absence of 4-CIN) in cortical slices of sham-operated, 
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BDL, HA and BDL-OP treated rats. p values indicate differences between 
responses recorded in the absence and presence of 4-CIN. B) Representative 
recordings of lactate biosensor current showing the effect of 4-CIN on tonic as 
well as hypoxia and 0 [Ca2+]e -induced release of lactate. C) Summary data 
illustrating means ± SE of the densitometry of MCT-1 protein levels, mainly 
expressed in astrocytes (Chemicon International, 0.5 µg/mL) normalized to 
the expression of Actin, in cell lysates of the cerebral cortices of sham-
operated, BDL, HA and BDL-OP treated rats. Bottom: Representative 
immunoblots showing MCT-1 protein expression in cerebral cortices of sham-
operated, BDL, HA and BDL-OP treated rats.  
 
Supplementary Table 1: Plasma biochemistry.  
Bile duct ligated (BDL), hyperammonemic (HA), ornithine phenylacetate 
treated BDL rats (BDL-OP); ALT, alanine aminotransferase. 
Data expressed as means±SEM, ** p<0.001 compared to sham group using 
one-way ANOVA.  
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Parameters Sham BDL HA BDL+OP 
N numbers 22 26 22 14 
Ammonia, μmol/L 56±3 141±4** 121±9** 60±2 
Albumin, g/L 35±4 23±0.4** 30±0.8 23±1 
Total protein, g/L 50±0.3 38±0.5** 51±3 40±1 
Bilirubin, μmol/L 5±0.5 205±3** 4±0.6 161±6 
ALT, U/L 11±0.4 130±2** 17±4 87±4 
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